LILRB1 and cancer: Our data thus indicate that LIR‐1+ expanded NK cells represent a subset with unique reactivity and have the potential to be utilised in both autologous and allogeneic adoptive NK cell protocols to safely and selectively target malignant cells in cancer patients.